{"id":1353,"date":"2025-06-02T15:15:08","date_gmt":"2025-06-02T09:45:08","guid":{"rendered":"https:\/\/mediumturquoise-hedgehog-745891.hostingersite.com\/blogs\/?p=1353"},"modified":"2026-03-11T11:21:02","modified_gmt":"2026-03-11T05:51:02","slug":"pharmaceutical-intermediates","status":"publish","type":"post","link":"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/","title":{"rendered":"Empowering India\u2019s Growth Through Pharmaceutical Intermediates &amp; API Production"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\">The Indian healthcare and pharmaceutical Intermediates are rapidly growing in unprecedneted areas which makes needs for unexplored resoures. The immense growth for healthcare services and suppl, includes government policies and global sourcing transformations which as the primary reasons that have Pharmaceutical Intermediates &amp; API Production. The outward focus of self sufficiency and backward integration is without a doubt raising India regarding being the pharmaceutical value manufacturing chain standalone, implying ecosystems that are entrepreneurial in nature, competitively sustained globally, and innovation in API and intermediates.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">In this paper, I have sorted out the current environment and opportunities, the classical debate of issues, and the framework forward from the lens of a start-up.<\/p>\r\n\r\n\r\n\r\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Definitions_of_APIs_and_pharmaceutical_Intermediates\" >Definitions of APIs and pharmaceutical Intermediates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Indias_Position_in_the_Global_API_Production_API_Industry\" >India\u2019s Position in the Global API Production API Industry<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Related_Best_Manufacturing_Business_Ideas_in_the_Active_Pharmaceutical_Ingredient_API_Products_Industry\" >Related: Best Manufacturing Business Ideas in the Active Pharmaceutical Ingredient (API) Products Industry<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Surge_in_the_Number_of_Startups_in_API_and_Intermediate_Manufacturing\" >Surge in the Number of Startups in API and Intermediate Manufacturing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Key_Parts_in_Start-Up_Investment\" >Key Parts in Start-Up Investment<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#A_Antiviral_APIs\" >A. Antiviral APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#B_Cardiovascular_Diabetics_APIs\" >B. Cardiovascular &amp; Diabetics APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#C_Oncological_APIs_and_Intermediates\" >C. Oncological APIs and Intermediates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#D_Veterinary_Science_APIs\" >D. Veterinary Science APIs<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Competitive_Advantages_of_Indian_Startups\" >Competitive Advantages of Indian Startups<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Government_Assistance_PLI_Schemes\" >Government Assistance &amp; PLI Schemes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Market_Size_and_Growth_Potential\" >Market Size and Growth Potential<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Models_That_Work_for_Startups\" >Models That Work for Startups<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Case_Study_Supriya_Lifescience_Ltd\" >Case Study: Supriya Lifescience Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Challenges_for_Startups_to_Overcome\" >Challenges for Startups to Overcome<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Related_Chemical_industry_on_Sodium_Sulphate_Anhydrous\" >Related: Chemical industry on Sodium Sulphate (Anhydrous)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Digital_and_Sustainable_Innovations\" >Digital and Sustainable Innovations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#International_Collaboration_and_Licensing_Deals\" >International Collaboration and Licensing Deals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Summary_Why_This_Is_the_Right_Time_for_Pharma_Startups\" >Summary: Why This Is the Right Time for Pharma Startups<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Definitions_of_APIs_and_pharmaceutical_Intermediates\"><\/span><strong>Definitions of APIs and pharmaceutical Intermediates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 APIs (Active Pharmaceutical Ingredients) are considered those parts of the drug product which assert the biological function of it and are responsible for delivering the effects designed.<br \/>\u2022 Pharmaceutical intermediates are chemical intermediates which serve as the components for API synthesis.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">In order to guarantee the efficacy, safety, and consistent regulatory approval of the drugs, the quality of the API and intermediate manufacturing needs to improve. By focusing on innovative processes and maintaining quality, start-ups can ensure that India emerges as a pillared central hub for drug manufacturing.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Indias_Position_in_the_Global_API_Production_API_Industry\"><\/span><strong>India\u2019s Position in the Global API Production API Industry<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">The overall exports of APIs in India are in the range of 20% of the world export volume making India the single largest producer of APIs in the world. Despite this standing, India still imports ~65% of its API requirements from foreign countries \u2013 China being one of the major suppliers. This degree of dependence raised a strategic alarm during the pandemic. There has been a paradigm shift in \u2018Indigenous API Production Policy\u2019 post-COVID.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">As for the PLI Scheme, it was launched with the intent of:<br \/>\u2022 Encouraging the establishment of new greenfield API units.<br \/>\u2022 Alleviating the dependency on imports.<br \/>\u2022 Providing financial incentives on incremental sales.<br \/>\u2022 Forming API clusters that can compete on a global level.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Related_Best_Manufacturing_Business_Ideas_in_the_Active_Pharmaceutical_Ingredient_API_Products_Industry\"><\/span>Related: <a href=\"https:\/\/www.niir.org\/blog\/best-manufacturing-business-ideas-in-the-active-pharmaceutical-ingredient-api-products-industry\/\" rel=\"nofollow noopener\" target=\"_blank\">Best Manufacturing Business Ideas in the Active Pharmaceutical Ingredient (API) Products Industry<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Surge_in_the_Number_of_Startups_in_API_and_Intermediate_Manufacturing\"><\/span><strong>Surge in the Number of Startups in API and Intermediate Manufacturing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">The April 15, 2025 issue of Chemical Weekly outlines a number of developments that indicate aggressive startup opportunities.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 Viruj Chematrix Pvt. Ltd. is a Hyderabad based vertically integrated API and intermediate manufacturer of antiviral, antibacterial, cardiovascular, and antidiabetic molecules.<br \/>\u2022 Supriya Lifescience Ltd. Is actively constructing its portfolio of API products by pharmaceutical intermediates used in antibiotics, antihypertensives, antidepressants, and antiobesity drugs.<br \/>\u2022 Laurus Labs \u2013 Planned to spend \u20b95,000 crore on a new API and specialty chemical facility in Andhra Pradesh. The production plant will focus on green chemistry, fermentation, and crop science chemicals.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Parts_in_Start-Up_Investment\"><\/span><strong>Key Parts in Start-Up Investment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"A_Antiviral_APIs\"><\/span><strong>A. Antiviral APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Products for managing viral infections, such as Baloxavir Marboxil and Daclatasvir, have greatly increasing demand due to the rising prevalence of chronic viral diseases.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"B_Cardiovascular_Diabetics_APIs\"><\/span><strong>B. Cardiovascular &amp; Diabetics APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">With India emerging as the diabetes capital of the world, APIs such as Ezetimibe, Imeglimin, and Finerenone have scalable and evergreen business models.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"C_Oncological_APIs_and_Intermediates\"><\/span><strong>C. Oncological APIs and Intermediates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">These medicines are underdeveloped in India. Ebruinib, Ruxolitinib, and Enzalutamide provide a good base for high-value, low-volume new ventures.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"D_Veterinary_Science_APIs\"><\/span><strong>D. Veterinary Science APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Vetrinary market APIs like Closantel have increasing international demand, presenting AVE for entrepreneurial new ideas.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Competitive_Advantages_of_Indian_Startups\"><\/span><strong>Competitive Advantages of Indian Startups<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>\u00a0Economic:<\/strong> Reduced expenses of operations in India creates a competitive edge in foreign markets.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><br \/><strong>\u00a0 Skilled Employees:<\/strong> There are Pharmacists, Chemists, and Engineers qualified in GMP, FDA, and EUGMP standards.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>\u00a0\u00a0Contract Manufacturing Model:<\/strong> Startups can operate as third-party manufacturers alongside leading drug companies.<br \/>\u00a0 Closest to Markets: Proximity to Southeast Asia, Africa, and the Middle East \u2013 all of which have huge unmet needs for generics and low-cost medicines.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Government_Assistance_PLI_Schemes\"><\/span><strong>Government Assistance &amp; PLI Schemes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Government of India is offering:<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 \u20b96,940 crore PLI for 53 essential APIs.<br \/>\u2022 Bulk drug parks cluster development with Himachal Pradesh, Gujarat, and Andhra Pradesh.<br \/>\u2022 Quick environmental clearances.<br \/>\u2022 Incentives for R&amp;D and backward integration.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">With these schemes, funded start-ups are able to reduce their expenses by 20-30% on setting up.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Market_Size_and_Growth_Potential\"><\/span><strong>Market Size and Growth Potential<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">The Indian API market was estimated at 12 billion dollars in 2024 and is projected to reach 18 billion dollars in 2028, growing at a CAGR of 8.5%. pharmaceutical Intermediates segment is likely to grow even faster because of:<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 Increased demand for exports<br \/>\u2022 Custom synthesis for big pharma companies worldwide<br \/>\u2022 High-margin products in niche therapeutic areas<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Models_That_Work_for_Startups\"><\/span><strong>Models That Work for Startups<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>Greenfield API Units<br \/><\/strong>These include the construction of headquarter-managed multidisciplinary GMP-certified units within designated areas or clusters of APIs, with a fully integrated supply chain.<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li><strong>Intermediate Specialization<br \/><\/strong>These specialize in individual and specific stages of the production of high-demand API drugs, such as anti-diabetics or antifungals.<\/li>\r\n\r\n\r\n\r\n<li><strong>Export-Oriented Startups<\/strong><br \/>Specialize in the supply of defined high-value API orders for regulated markets (USFDA, EUGMP approved).<\/li>\r\n\r\n\r\n\r\n<li><strong>CDMO Startups<\/strong><br \/>Contract Development and Manufacturing Organizations includes process development, clinical trial material and manufacturing, as well as commercial manufacturing.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Case_Study_Supriya_Lifescience_Ltd\"><\/span><strong>Case Study: Supriya Lifescience Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Supriya has over 38 APIs in its portfolio and has received numerous certifications that include US DMF, CEP, KDMF, and HALAL for major APIs like:<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 Atorvastatin Calcium<br \/>\u2022 Hydroxocobalamin<br \/>\u2022 Allopurinol<br \/>\u2022 Bisoprolol Fumarate<br \/>\u2022 Chloramphenicol Palmitate<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">The company\u2019s extensive R&amp;D and overseas registrations serve as the blueprint for many new startups in the regulated markets.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Challenges_for_Startups_to_Overcome\"><\/span><strong>Challenges for Startups to Overcome<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">There are some hurdles for startups that are quite challenging, even with the optimistic prospects for the future:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>Elevated Initial Capital Expenditure for GMP facilities.<\/li>\r\n\r\n\r\n\r\n<li>Lengthy USFDA\/EDQM approval timelines.<\/li>\r\n\r\n\r\n\r\n<li>Instability of primary feedstock, especially imported solvents and reagents.<\/li>\r\n\r\n\r\n\r\n<li>Meeting environmental standards, especially for effluent and solvent treatment.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">These are possible through:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>Plant configurations with discrete modules.<\/li>\r\n\r\n\r\n\r\n<li>Strategic partnerships with CRO and contract labs.<\/li>\r\n\r\n\r\n\r\n<li>Use of AI and automation in maintaining batch controls, data integrity, and more.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Related_Chemical_industry_on_Sodium_Sulphate_Anhydrous\"><\/span>Related: <a href=\"https:\/\/www.entrepreneurindia.co\/blog-description\/15005\/chemical+industry+on+sodium+sulphate+(anhydrous)\">Chemical industry on Sodium Sulphate (Anhydrous)<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Digital_and_Sustainable_Innovations\"><\/span><strong>Digital and Sustainable Innovations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Newer startups are focusing on the following:<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 Recycling Process for Solvents<br \/>\u2022 Plant Safety Digital Twin Simulations<br \/>\u2022 Flow Chemistry for Dangerous Reactions<br \/>\u2022 Green Chemistry Pathways<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">These processes help to achieve critical Environmental, Social, and Governance (ESG) objectives for strategic international collaborations while maintaining operational profitability.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"International_Collaboration_and_Licensing_Deals\"><\/span><strong>International Collaboration and Licensing Deals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">In the April 2025 issue<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 Emcure Pharmaceutical intermediates added a non-invasive dermatology license from WiQo, expanding its portfolio.<br \/>\u2022 Tillomed Laboratories (UK) acquired the pharmaceutical product portfolio of Manx Healthcare, further broadening its therapeutic range.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">These serve to illustrate the stunning pace at which Indian enterprises are emerging as leaders in the global pharmaceutical licensing arena\u2014glorious to be tracked by startups.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Summary_Why_This_Is_the_Right_Time_for_Pharma_Startups\"><\/span><strong>Summary: Why This Is the Right Time for Pharma Startups<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">New entrants in the domains of specialty APIs, contract manufacturing, niche intermediates, and Veterinary and nutraceutical APIs will leave an indelible mark on the industry, thanks to robust government policy support, the ongoing worldwide API reshoring initiative, and India\u2019s unparalleled pharma infrastructure.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Pharma startups oriented around sustainability and compliance will have ample opportunity to thrive, partner, and compete on a global scale.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">The opportunities in entrepreneurship are enormous with India&#8217;s growth in the business of pharma manufacturing. The start-up&#8217;s production of API and intermediates will benefit from India&#8217;s cost factors and human resources, as well as the government thrust on self-reliance and exports.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">Niir Project Consultancy Services (NPCS) offers specialized Market Survey cum Detailed Techno Economic Feasibility Reports which include services on:<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">\u2022 Manufacturing Process &amp; Plant Setup<br \/>\u2022 Financial Projections &amp; ROI<br \/>\u2022 Raw Material Procurement<br \/>\u2022 Licensing &amp; Regulation<br \/>\u2022 Export Market Trends<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">With the NPCS report on hand, the guidance we provide is helping transform aspirations in pharma into reality.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\">&nbsp;<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>The Indian healthcare and pharmaceutical Intermediates are rapidly growing in unprecedneted areas which makes needs for unexplored resoures. The immense growth for healthcare services and suppl, includes government policies and global sourcing transformations which as the primary reasons that have Pharmaceutical Intermediates &amp; API Production. The outward focus of self sufficiency and backward integration is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1354,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard","override":[{"template":"2","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"topbottom","share_float_style":"share-monocrhome","show_share_counter":"1","show_view_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"0","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","show_comment_section":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"0","show_inline_post_related":"0"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0","subtitle":""},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_paywall_metabox":{"paragraph_limit":"2","enable_premium_post":"0","enable_free_post":"0","override_paragraph_limit":"0","enable_preview_post":"0","enable_preview_video":"0"},"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[1225],"tags":[],"class_list":["post-1353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-industry"],"_links":{"self":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts\/1353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/comments?post=1353"}],"version-history":[{"count":5,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts\/1353\/revisions"}],"predecessor-version":[{"id":5847,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts\/1353\/revisions\/5847"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/media\/1354"}],"wp:attachment":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/media?parent=1353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/categories?post=1353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/tags?post=1353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}